Bottom line
How has LYFAX performed?
As of Dec 31, 2025, LYFAX returned +20.6% over the past year, +4.1% a year over five years. That means $10,000 invested five years earlier would have grown to about $12,200. Its five-year return beat 47% of health care sector funds we track. Its best quarter was +27.5% and its worst −11.9%.
Updated Dec 31, 2025
LYFAX annual returns by year
| Year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| LYFAX | +27.9% | −0.4% | +6.9% | −1.1% | −3.6% | +54.4% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in LYFAX
$10,000 invested at the start of 2020 would have been worth about $20,000 by the end of 2025, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2025 | +27.9% | $20,045 |
| 2024 | −0.4% | $15,673 |
| 2023 | +6.9% | $15,743 |
| 2022 | −1.1% | $14,729 |
| 2021 | −3.6% | $14,886 |
| 2020 | +54.4% | $15,443 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| LYFAX | +20.6% | +4.1% | — | +11.3% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% | — |
Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending Jun 30, 2026, LYFAX returned +0.32%, +4.50%, +12.24% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.